Loading insider details...
Beta
Latest Form 4 (Sep 18, 2026): Sale of 3,674 ARQT shares, $91.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 18, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale | 3,674 | $91.9K |
| Sep 10, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale | 9,989 | $250.0K |
| Aug 6, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale | 1,230 | $32.1K |
| May 6, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale | 7,372 | $171.5K |
| Mar 4, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/Award | 37,000 | n/a |
| Feb 5, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale | 7,983 | $203.6K |
| Dec 3, 2025 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale | 1,657 | $50.1K |
| Nov 21, 2025 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale | 989 | $27.6K |
| Nov 5, 2025 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale | 7,165 | $177.1K |
| Sep 8, 2025 | Arcutis Biotherapeutics, Inc. (ARQT) | Sale | 36,130 | $583.7K |